Voyager struggles with a negative enterprise value, financial risks, and limited catalysts in a competitive Alzheimer's ...

Neuroscience technology company Brooklyn Health is using artificial intelligence to target a fundamental problem in neurology ...

With U.S. stocks booming, North American wealthy led the way globally. And the top 1% of wealthy globally—the so-called ...

TEM is a data-rich platform that recently clinched a $200 million deal with AstraZeneca. TEM’s main bet is now on AI for ...